These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 11861387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
    Shingu T, Yamada K, Hara N, Moritake K, Osago H, Terashima M, Uemura T, Yamasaki T, Tsuchiya M.
    Cancer Res; 2003 Jul 15; 63(14):4044-7. PubMed ID: 12874004
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Kawagoe J, Takahashi K, Yada-Hashimoto N, Seino-Noda H, Sakata M, Motoyama T, Kurachi H, Testa JR, Tasaka K, Murata Y.
    Clin Cancer Res; 2004 Nov 15; 10(22):7645-54. PubMed ID: 15569997
    [Abstract] [Full Text] [Related]

  • 6. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
    Hu L, Hofmann J, Jaffe RB.
    Clin Cancer Res; 2005 Nov 15; 11(22):8208-12. PubMed ID: 16299254
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
    Hu L, Hofmann J, Zaloudek C, Ferrara N, Hamilton T, Jaffe RB.
    Am J Pathol; 2002 Nov 15; 161(5):1917-24. PubMed ID: 12414537
    [Abstract] [Full Text] [Related]

  • 8. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 15; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
    Xie X, Tang B, Zhou J, Gao Q, Zhang P.
    Oncol Rep; 2013 Aug 15; 30(2):773-82. PubMed ID: 23743572
    [Abstract] [Full Text] [Related]

  • 10. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
    Zhang PN, Sun H.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar 15; 42(3):196-200. PubMed ID: 17537308
    [Abstract] [Full Text] [Related]

  • 11. [Inhibitory effect of tirapazamine combined with phosphatidylinositol 3-kinase inhibitor LY294002 to ovarian cancer cells].
    Ren Y, Zha X, Zhang GN.
    Zhonghua Yi Xue Za Zhi; 2007 May 08; 87(17):1204-6. PubMed ID: 17686243
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of triptolide as an adjunct chemotherapy for ovarian cancer.
    Westfall SD, Nilsson EE, Skinner MK.
    Chemotherapy; 2008 May 08; 54(1):67-76. PubMed ID: 18073474
    [Abstract] [Full Text] [Related]

  • 14. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C, Liu VW, Chan DW, Yao KM, Ngan HY.
    Int J Gynecol Cancer; 2012 Jan 08; 22(1):15-22. PubMed ID: 22080879
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS.
    J Thorac Cardiovasc Surg; 2004 Feb 08; 127(2):365-75. PubMed ID: 14762343
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells.
    Semba S, Itoh N, Ito M, Harada M, Yamakawa M.
    Clin Cancer Res; 2002 Jun 08; 8(6):1957-63. PubMed ID: 12060641
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.
    MacKeigan JP, Taxman DJ, Hunter D, Earp HS, Graves LM, Ting JP.
    Clin Cancer Res; 2002 Jul 08; 8(7):2091-9. PubMed ID: 12114408
    [Abstract] [Full Text] [Related]

  • 19. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
    Guo RX, Zhang RF, Wang XY, Shi HR, Qiao YH.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun 08; 46(6):446-52. PubMed ID: 21781587
    [Abstract] [Full Text] [Related]

  • 20. The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.
    Garofalo A, Naumova E, Manenti L, Ghilardi C, Ghisleni G, Caniatti M, Colombo T, Cherrington JM, Scanziani E, Nicoletti MI, Giavazzi R.
    Clin Cancer Res; 2003 Aug 15; 9(9):3476-85. PubMed ID: 12960140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.